Aurobindo Pharma gets USFDA nod for generic Tranexamic acid injection

By: |
New Delhi | January 17, 2016 1:49 AM

Aurobindo Pharma has received final approval from the USFDA to manufacture and market its Tranexamic acid injection, used for treating hemophilia, in the American market. The company plans to launch the product by the end of this fiscal.

"The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Tranexamic acid injection, (100 mg/mL) 1000 mg/10 mL single-dose vial," Aurobindo Pharma said in a statement. (Reuters)‘The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Tranexamic acid injection, (100 mg/mL) 1000 mg/10 mL single-dose vial,’ Aurobindo Pharma said in a statement. (Reuters)

Aurobindo Pharma has received final approval from the USFDA to manufacture and market its Tranexamic acid injection, used for treating hemophilia, in the American market.
The company plans to launch the product by the end of this fiscal.

“The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Tranexamic acid injection, (100 mg/mL) 1000 mg/10 mL single-dose vial,” Aurobindo Pharma said in a statement.

The approved abbreviated new drug application (ANDA) is generic version of Pharmacia and Upjohn Company’s Cyklokapron injection in the strength of 100 mg/mL, it added.

“The approved product has an estimated market size of USD 50 million for the twelve months ending November 2015, according to IMS,” it said.

Tranexamic acid injection is used in the treatment of short-term control of bleeding in people suffering from hemophilia, including dental extraction procedures. This product is in the WHO list of essential medicines, it added.

Hemophilia is a group of hereditary genetic disorders that impairs the body’s ability to control blood clotting, which is used to stop bleeding when a blood vessel is broken.

Aurobindo Pharma currently has a total of 232 ANDA approvals (201 final approvals including 10 from Aurolife Pharma LLC and 31 tentative approvals) from USFDA.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Nestle India increasing number of female employees; 42% of new hires in 2020 were women
2Criticism should not be at cost of national dignity: Gautam Adani on India’s Covid handling
3RBI Deputy Governor M Rajeshwar Rao stresses on need to mainstream green finance